SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Chemkart India Ltd (544442)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 544442 NSE: Trading | Small Cap | Chemkart India Share Price

₹140 0.00 (0.00%)

As on 09-Jun'26 16:59

Chemkart India Ltd (544442)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 544442 NSE: Trading | Small Cap | Chemkart India Share Price

₹140 0.00 (0.00%)

As on 09-Jun'26 16:59

Key Metrics
Valuation Multiples
Market Cap
₹169 Cr.
Current Price
₹140
52-Week Low / High
₹87 / 262
TTM EPS
₹17.2
TTM Sales
₹213 Cr.
Book Value per Share
₹108.3
P/E Ratio
8.15
Lower than its 5-year historical median
Industry PE
36.2
Price to Book (P/B)
1.29
Price to Sales (P/S)
0.80
Lower than its 5-year historical median
EV/EBITDA
6.08
Lower than its 5-year historical median
Dividend Yield
0.00%
Profitability Efficiency
Return on Equity (ROE)
63.98%
Outperforms industry median
Return on Capital Employed (ROCE)
62.04%
Outperforms industry median
Return on Assets (ROA)
29.53%
Operating Profit Margin
15.4%
Net Profit Margin
10.56%
Gross Profit Margin
15%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
-
0.49%
Operating Profit Growth (1 Year)
-
76.76%
Net Profit Growth (1 Year)
-
74.91%
Asset Quality
Promoter Holding
74.66%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹119 Cr.
Equity
₹12.1 Cr.
Face Value
₹10
All Time Low / High
₹87.00 / 262.00

Chemkart India stock performance

Key Ratios
mw4me loader

Check Before You Invest

Valuation

Somewhat Undervalued

Price Trend

Weak
Q.1 Is Chemkart India Ltd a good quality company?
Chemkart India Ltd is a weak quality company, based on a inconsistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

How does Chemkart India Ltd performance compare with that of its Peers?
Q.1 Revenue growth of Chemkart India Ltd vs industry peers?
Chemkart India Ltd revenue CAGR is 0.00%, compared to the industry median CAGR of 4.99%, indicating slower growth and losing its market share.
Q.1 Promoter shareholding and pledge status of Chemkart India Ltd?
Promoters hold 74.66% of the Chemkart India Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Q.1 Stock return of Chemkart India Ltd over the last decade?
Over the last - year(s), the stock has delivered a CAGR of N/A% based on the current price.

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Chemkart India Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Mar'22Mar'23Mar'24TTM
ROCE % 83.2%66.8%62%-
Value Creation
Index
4.93.83.4-

Growth Parameters

Sales 87131132213
Sales YoY Gr.-51.1%0.5%-
Adj EPS 5.58.214.117.2
YoY Gr.-49.9%72.5%-
BVPS (₹) 7.215.630.3108.3
Adj Net
Profit
5.27.813.421
Cash Flow from Ops. -04.61.3-
Debt/CF from Ops. -86.12.49.8-

CAGR

9 Years 5 Years 3 Years 1 Years
Sales NANANA0.5%
Adj EPS NANANA72.5%
BVPSNANANA94%
Share Price - - - -

Key Financial Parameters

Mar'22Mar'23Mar'24TTM
Return on
Equity %
75.671.661.424.8
Op. Profit
Mgn %
8.18.715.4NAN
Net Profit
Mgn %
65.910.19.8
Debt to
Equity
0.30.70.4-
Working Cap
Days
0831150
Cash Conv.
Cycle
036620

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24
Sales87131132
Operating Expenses + 80120112
Manufacturing Costs442
Material Costs71111105
Employee Cost 101
Other Costs 454
Operating Profit 71120
Operating Profit Margin (%) 8.1%8.7%15.4%
Other Income + 001
Exceptional Items 000
Interest 011
Depreciation 000
Profit Before Tax 71119
Tax 236
Profit After Tax 5814
PAT Margin (%) 6.3%6.1%10.6%
Adjusted EPS (₹)5.88.414.7
Dividend Payout Ratio (%)0%0%0%

Valuation of Chemkart India - Standalone

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24

Equity and Liabilities

Shareholders Fund + 71529
Share Capital 111
Reserves 51327
Debt +21112
Long Term Debt000
Short Term Debt21112
Minority Interest000
Trade Payables131110
Others Liabilities 433
Total Liabilities 264054

Fixed Assets

Net Fixed Assets +165
Gross Block166
Accumulated Depreciation000
CWIP 000
Investments 000
Inventories288
Trade Receivables192232
Cash Equivalents 000
Others Assets 449
Total Assets 264054

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24
Cash Flow From Operating Activity + -051
PBT 71119
Adjustment 002
Changes in Working Capital -6-4-14
Tax Paid -2-3-5
Cash Flow From Investing Activity + -1-5-0
Capex -1-5-0
Net Investments 000
Others 000
Cash Flow From Financing Activity + 11-1
Net Proceeds from Shares 100
Net Proceeds from Borrowing -110
Interest Paid 00-1
Dividend Paid 000
Others 000
Net Cash Flow -00-0

Financial Ratio

PARTICULARSMar'22Mar'23Mar'24
Ratios
ROE (%)80.1773.6163.98
ROCE (%)83.266.8162.04
Asset Turnover Ratio3.373.972.8
PAT to CFO Conversion(x)-00.630.07
Working Capital Days
Receivable Days80.5057.9075.20
Inventory Days813.4021.50
Payable Days6539.5036.80

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.00
* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Chemkart India Ltd FAQs

The current trading price of Chemkart India on 09-Jun-2026 16:59 is ₹140.0.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 08-Jun-2026 the market cap of Chemkart India stood at ₹169.4 Cr

The latest P/E ratio of Chemkart India as of 08-Jun-2026 is 8.15.

The latest P/B ratio of Chemkart India as of 08-Jun-2026 is 1.29.

The 52-week high of Chemkart India is ₹262.0 and the 52-week low is ₹87.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Chemkart India is ₹213 ( Cr.) .

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Chemkart India Ltd is a below average quality company.

The key valuation ratios of Chemkart India Ltd's currently when compared to its past seem to suggest it is in the Somewhat Undervalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Chemkart India Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Chemkart India Ltd

Chemkart India Limited was incorporated on March 06, 2020 as ‘Chemkart India Private Limited’, a private limited company under the Companies Act, 2013 pursuant to a certificate of incorporation dated March 06, 2020 issued by Deputy Registrar of Companies. Further, the company was converted into a public limited company pursuant to a resolution passed by the Board of Directors in their meeting held on August 16, 2024 and by its Shareholders at an Extra-Ordinary General Meeting held on August 16, 2024 at shorter notice and consequently the name of the company was changed to ‘Chemkart India Limited’ and a fresh certificate of incorporation dated October 04, 2024 was issued by Assistant Registrar of Companies/Deputy Registrar of Companies/ Registrar of Companies, Central Processing Centre.

The company is a one stop destination for various nutritional, Health and sports supplement products, which are largely biased towards the food products providing health benefits in addition to their nutritional values, reflecting its ability in catering to nutritional as well as health needs of the end customers. The company is based in Mumbai, offering diverse range of captivated nutritional supplements and components. It offers products across mainly seven product categories, i.e. Amino Acids, Health Supplement, Herbal Extract, Nucleotide, Protein, Sports Nutrition, and Vitamin. 

It targets the Business to Business (B-to-B) platform which uses its products into manufacturing of finished supplements which includes sports supplements, health supplements, vitamins, protein products etc. Its product assortment and customer-centric approach aims to fulfil the daily and aspirational requirements of the end customers with a focus on variety, affordability, quality and convenience. Since the commencement of its operations, it has developed good standing relationships with its customers. It also engages actively with its suppliers to improve its supply chain processes.

Business area of the company

The company is mainly engaged in the business of processing and trading of nutritional and health supplements. The company is registered under FSSAI (Food Safety and Standards Authority of India)

Products of the company

  • Amino acid
  • Health supplement
  • Herbal extract
  • Nucleotide
  • Protein
  • Sports nutrition
  • Vitamin

History and milestones

  • 2020: Incorporation of the company as a private limited company under the name ‘Chemkart India Private Limited’
  • 2020: ISO 9001:2015 Quality Management System certified for the following activities Importers, Manufacturers and distributors of Health Supplements, Pharma Bulk Drugs, Food and Feed Ingredients.
  • 2021: Received FSSAI License.
  • 2024: Certificate of registration re-issued to certify that the quality management systems of the company have been audited and have found to be compliant with standards prescribed under ISO 9001:2015 Received FSSAI License.
  • 2024: Certificate of Compliance issued and assessed by GACB that the Plant situated at Office No. 403/404, 4th Floor, K.L. Accolade, 6th Road, TPS III, Santacruz (East), Mumbai, Maharashtra, India, has been audited and assessed and found to comply with the requirements of the HALAL Assurance System Guidelines.
  • 2024: Certificate of Compliance issued that confirms that the products manufactured by the company are KOSHER.
  • 2024: Certificate of registration issued to certify that audit has been conducted by ICV and found to be in compliance with the quality management systems with standards prescribed under ISO 9001:2015.
  • 2024: Converted to Public Limited Company and Name changed to Chemkart India Limited.
  • 2024: The company entered into Share Purchase Agreement to acquire majority stake of Easy Raw Materials.
  • Private Limited and Vinstar Biotech Private Limited.

You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×